Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron Lozenge for PONV in Pediatric Squint Surgery
NCT06423820Completed
- Sponsor
- Tanta University
- Start
- May 2024
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ondansetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Tanta University. Primary endpoint: Incidence of postoperative nausea and vomiting. Started May 2024; status: completed.
02
Drugs
ondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT06423820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06423820.